| Term 
 
        | Side effects of Class 1a Anti-arrhythmics |  | Definition 
 
        | Refractory Heterogeneity-> Torsades de pointes-> Recurrent lightheadedness-Quinidine Synecopy Vagolytic Quinidine- Increases Digitalis levels Procainamide- Transient Lupus Symptoms |  | 
        |  | 
        
        | Term 
 
        | Side effects of Class 1b Anti-arrhythmics |  | Definition 
 
        | CNS Side Effects: Tremor, Nausea, Light-headedness B-blockers increase lidocaine clearance |  | 
        |  | 
        
        | Term 
 
        | Side effects of Class 1c Anti-arrhythmics |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Side effects of Class 2 Anti-arrhythmics |  | Definition 
 
        | Hypotension, Bradycardia Increases Clearance of Lidocaine Never with Ca Channel Blockers |  | 
        |  | 
        
        | Term 
 
        | Side effects of Class 3 Anti-arrhythmics |  | Definition 
 
        | Amiodarone- Pulmonary Fibrosis, Hypo/Hyperthyroid, Decreased SA/AV/Inotropy/Tension, Increased Liver enzymes, Tremor/Ataxia/Headaches/Peripheral Neuropathy, Corneal Microdeposits/ Testicular Dysfunction/Skin Discoloration Bretylium- Trans Increase, Perminant Decrease in Catecholamines |  | 
        |  | 
        
        | Term 
 
        | Side effects of Class 4 Anti-arrhythmics |  | Definition 
 
        | Hypotension/Bradycardia, Never with B-blockers |  | 
        |  | 
        
        | Term 
 
        | Limitations to Adenosine Use |  | Definition 
 
        | Short Half-Life Caffeine/Theophylline Block |  | 
        |  | 
        
        | Term 
 
        | Indication for Class 1a Anti-Arrhythmics |  | Definition 
 
        | Quinidine- All esp A.Fib/A.Flut Procainamide- Ventricular Arrhythmias after MI Disopyramide- Venticular arrhythmias PSVT |  | 
        |  | 
        
        | Term 
 
        | Indication for Class 1b Anti-Arrhythmics |  | Definition 
 
        | Ventricular Arrhythmias, Digitalis Induced Arrythmias |  | 
        |  | 
        
        | Term 
 
        | Indication for Class 1c Anti-Arrhythmics |  | Definition 
 
        | Paroxysomal Supraventricular Tachycardia Ventricular Tachycardia A.Fib/A.Flut |  | 
        |  | 
        
        | Term 
 
        | Indication for Class 2 Anti-Arrhythmics |  | Definition 
 
        | Stabilize Ventrical in A.Fib/A.Flut Ventricular Re-Entry Arrhythias PAC, PVC, PSVT Ischemia-Related Ventricular Tachycardia |  | 
        |  | 
        
        | Term 
 
        | Indication for Class 3 Anti-Arrhythmics |  | Definition 
 
        | Amio- A.Fib/A.Flut Ventricular Tachycardia Bypass-Tract(Kent) PSVT |  | 
        |  | 
        
        | Term 
 
        | Indication for Class 4 Anti-Arrhythmics |  | Definition 
 
        | Protect Ventrical in A.Fib/A.Flut Multifocal Atrial Tachycardia PSVT |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Paroxisomal Supraventrical Tachycardia |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Class 1a Anti-arrhythmics |  | Definition 
 
        | Decrease Na Conduction Mild Decrease in K conduction
 |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Class 1b Anti-arrhythmics |  | Definition 
 
        | Decrease Na conduction in Depolarized and Active Heart Tissue, but not Resting Tissue |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Class 1c Anti-Arrhythmics |  | Definition 
 
        | Na: Block Fast Na Conduction AV: Decrease condution -> Widen QRS Prolong AP Effective on His-Purkinje System |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Class 2 Anti-arrhythmics |  | Definition 
 
        | Decrease AV Node conduction Decrease SA Node Firing
 Decrease K Conduction
 |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Class 3 Anti-arrhythmics |  | Definition 
 
        | Amodarone- 1,2,3 Ibutilide- 3
 Sotalol- 2,3
 |  | 
        |  | 
        
        | Term 
 
        | Mechanism of Class 4 Anti-Arrhythmics |  | Definition 
 
        | Ca Channel Block Decrease AV/SA Node Conduction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Increase K Conduction Decrease Ca Conduction
 Effective on the AV Node
 |  | 
        |  | 
        
        | Term 
 
        | Class 1a Anti-Arrhythmics |  | Definition 
 
        | Quinidine, Procainamide, Disopyramide |  | 
        |  | 
        
        | Term 
 
        | Class 1b Anti-Arrhythmics |  | Definition 
 
        | Lidocaine Tocainide Mexiletine Phenytoin |  | 
        |  | 
        
        | Term 
 
        | Class 1c Anti-Arrhythmics |  | Definition 
 
        | Flecainide Moricizine Propafenone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sotalol, Propanolol, Acebutylol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Amiodarone, Sotalol, Ibutilide, Bretylium |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Treatment of Paroxysomal Supraventricular Tachycardia |  | Definition 
 
        | Acute: Adenosine, Verapamil, Diltiazem Chronic: Oral Verapamil, Diltiazem, or Class 2 |  | 
        |  | 
        
        | Term 
 
        | Treatment of Atrial Fribillation |  | Definition 
 
        | Rate: Class 2 or Class 4 Rhythm: Class 1c of 3 |  | 
        |  | 
        
        | Term 
 
        | Treatment of Ventricular Arrhythmias |  | Definition 
 
        | IV Lidocaine, Flecainide, Amiodarone |  | 
        |  | 
        
        | Term 
 
        | What should you be aware of when using lidocaine  with a patient on Beta-blockers |  | Definition 
 
        | B-blockers decrease the clearance of lidocaine |  | 
        |  | 
        
        | Term 
 
        | If a patient is in an arrythmic beat has aslo been taking Digoxin what anti-arrythmic drug is indicated and which anti-arrythmic is contra-indicated? |  | Definition 
 
        | Indicated: Class 1b Contraindicated: Quinidine |  | 
        |  |